Atlas Trials

Concurrent or Sequential Immunotherapy and Radiation Therapy in Patients With Metastatic Lung Cancer

Clinical trial NCT03223155 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03223155
Sponsor
University of Chicago
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Stage IV Small Cell Lung Cancer
Start date
2017-09-07
Primary completion
2026-12-01
Enrollment
78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.